1. Colonic epithelial cathelicidin (LL‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate. (14th May 2021) Authors: Porter, Ross J; Murray, Graeme I; Alnabulsi, Abdo; Humphries, Matthew P; James, Jacqueline A; Salto‐Tellez, Manuel; Craig, Stephanie G; Wang, Ji M; Yoshimura, Teizo; McLean, Mairi H Journal: Journal of pathology Issue: Volume 7:Number 5(2021) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CXCR2 inhibition suppresses acute and chronic pancreatic inflammation. Issue 1 (4th June 2015) Authors: Steele, Colin W; Karim, Saadia A; Foth, Mona; Rishi, Loveena; Leach, Joshua DG; Porter, Ross J; Nixon, Colin; Jeffry Evans, TR; Carter, C Ross; Nibbs, Robert JB; Sansom, Owen J; Morton, Jennifer P Journal: Journal of pathology Issue: Volume 237:Issue 1(2015) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Endoscopically placed venting gastrostomy can be a safe and effective palliative intervention in benign and malignant gastrointestinal obstruction. Issue 4 (20th September 2021) Authors: Porter, Ross J; McKinlay, Alastair W; Metcalfe, Emma L Journal: Frontline gastroenterology Issue: Volume 13:Issue 4(2022) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit. Issue 5 (13th November 2019) Authors: Porter, Ross J; McKinlay, Alastair W; Metcalfe, Emma L Journal: Frontline gastroenterology Issue: Volume 11:Issue 5(2020) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines. (10th June 2021) Authors: Porter, Ross J; Arends, Mark J; Churchhouse, Antonia M D; Din, Shahida Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 12(2021) Page Start: 2131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lessons from recent medical history: an obsolete anti-reflux device in an older patient with variable gastrointestinal symptoms. (26th May 2021) Authors: Squires, Charlotte; Porter, Ross J; Ward, Benjamin M Journal: Age and ageing Issue: Volume 50:Number 4(2021) Page Start: 1426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PTH-053 Venting percutaneous endoscopic gastrostomy (vPEG): six year experience from a tertiary referral centre. (June 2019) Authors: Porter, Ross J; Leggett, Gillian; McKinlay, Alistair; Metcalfe, Emma L Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PTH-106 Predicting response to vedolizumab in Crohn's disease – a single centre experience. (June 2019) Authors: Kane, Claire; Porter, Ross J; Thomson, John; Smith, Malcolm; Basavaraju, Umesh; Bain, Gillian H; McLean, Mairi H Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PTU-056 Loss of cathelicidin (LL-37) is associated with colorectal cancer progression. (8th June 2018) Authors: Porter, Ross J; Murray, Graeme I; Wang, Ji M; Yoshimura, Teizo; McLean, Mairi H Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗